申请人:Janssen Pharmaceutica NV
公开号:US08338426B2
公开(公告)日:2012-12-25
The present invention is directed to piperazinyl derivatives useful as inhibitors of the NPY Y2 receptor, pharmaceutical compositions comprising said compounds, processes for the preparation of said compounds and the use of said compounds for the treatment and/or prevention of disorders, diseases and conditions mediated by the NPY Y2 receptor.
本发明涉及对吡哌啶衍生物的使用,作为NPY Y2受体的抑制剂,包括所述化合物的制药组合物,制备所述化合物的过程以及使用所述化合物治疗和/或预防由NPY Y2受体介导的疾病、疾病和状况。